Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.

Εμφάνιση άλλων εκδόσεων (1)

OBJECTIVES: Reports have suggested that a reduction in tumour 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) examination during or after neoadjuvant chemotherapy may predict pathological response in oesophageal cancer. Our aim was to determine whether metabolic response pr...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Gillies, R, Middleton, MR, Blesing, C, Patel, K, Warner, N, Marshall, R, Maynard, N, Bradley, K, Gleeson, F
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2012

Παρόμοια τεκμήρια

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
ανά: Gillies, R, κ.ά.
Έκδοση: (2012)

Challenges in assessing response of oesophageal cancer to neoadjuvant therapy, and the potential of composite PET-CT and multimodal metrics.
ανά: Findlay, J, κ.ά.
Έκδοση: (2017)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
ανά: Gillies, R, κ.ά.
Έκδοση: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
ανά: Gillies, R, κ.ά.
Έκδοση: (2012)

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.
ανά: Findlay, J, κ.ά.
Έκδοση: (2017)

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer
ανά: Gillies, R, κ.ά.
Έκδοση: (2011)

Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
ανά: Gillies, R, κ.ά.
Έκδοση: (2011)

Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer
ανά: Gillies, R, κ.ά.
Έκδοση: (2010)

Predicting pathological response of esophageal cancer to neoadjuvant chemotherapy: the implications of metabolic nodal response for personalised therapy
ανά: Findlay, J, κ.ά.
Έκδοση: (2016)

Role of adjuvant radiotherapy following neo-adjuvant chemotherapy (NACT) and surgery in oesophageal cancer - a multi-centre retrospective cohort study
ανά: Teoh, S, κ.ά.
Έκδοση: (2016)

The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.
ανά: Chowdhury, F, κ.ά.
Έκδοση: (2008)

Neoadjuvant chemotherapy for oesophageal carcinoma - a risk factor for postoperative pneumonia?
ανά: Millo, J, κ.ά.
Έκδοση: (2003)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
ανά: Findlay, J, κ.ά.
Έκδοση: (2016)

Survival after curative chemoradiotherapy or neoadjuvant therapy and surgery converges in higher-risk patients with oesophageal cancer
ανά: Rana, M, κ.ά.
Έκδοση: (2021)

Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
ανά: den Boer, RB, κ.ά.
Έκδοση: (2020)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
ανά: John M. Findlay, κ.ά.
Έκδοση: (2016-04-01)

A reply to evidence-based radiation oncology: oesophagus.
ανά: Gillies, R, κ.ά.
Έκδοση: (2010)

A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma
ανά: Kieran G. Foley, κ.ά.
Έκδοση: (2021-06-01)

Adjuvant radiotherapy following neo-adjuvant chemotherapy and surgery in oesophageal cancer: a retrospective cohort study of survival
ανά: Teoh, S, κ.ά.
Έκδοση: (2018)

Assessment of Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Using MRI and 18F FDG PET/CT
ανά: Reem Yusuf AlBuainain, κ.ά.
Έκδοση: (2025-01-01)

Role of F-18 FDG PET/CT in Predicting Response to Neoadjuvant Chemotherapy in Invasive Ductal Breast Cancer
ανά: Tarik Sengoz, κ.ά.
Έκδοση: (2023-04-01)

Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy
ανά: Han Wonshik, κ.ά.
Έκδοση: (2011-10-01)

PET/CT staging and response evaluation of post-transplantation lymphoproliferative disease (PTLD).
ανά: Chowdhury, F, κ.ά.
Έκδοση: (2009)

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy
ανά: A. G. M. T. Powell, κ.ά.
Έκδοση: (2020-08-01)

Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.
ανά: Alexander M Th Schmitz, κ.ά.
Έκδοση: (2017-01-01)

Direct comparison of PET/CT and MRI to predict the pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis
ανά: Lihua Chen, κ.ά.
Έκδοση: (2017-08-01)

Routinely staging gastric cancer with 18F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgery
ανά: Findlay, J, κ.ά.
Έκδοση: (2019)

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
ανά: Turkington, RC, κ.ά.
Έκδοση: (2019)

Whole transcriptome analysis of breast tumors during neoadjuvant chemotherapy: association with response to preoperative chemotherapy
ανά: M. K. Ibragimova, κ.ά.
Έκδοση: (2022-03-01)

Clinical value of SUVpeak-to-tumor centroid distance on FDG PET/CT for predicting neoadjuvant chemotherapy response in patients with breast cancer
ανά: Sun-pyo Hong, κ.ά.
Έκδοση: (2024-10-01)

Prognostic value of 18F-FDG PET and PET/CT for assessment of treatment response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis
ανά: Sangwon Han, κ.ά.
Έκδοση: (2020-10-01)

Efficacy Of 18FDG-PET/CT In Predicting Response After Neoadjuvant Chemoradiation In Rectal Cancer
ανά: Narendra Pandit, κ.ά.
Έκδοση: (2023-08-01)

Comparison between body composition parameters and response to neoadjuvant chemotherapy by using pre-treatment PET CT in locally advanced breast cancer
ανά: Inci Kizildag Yirgin, κ.ά.
Έκδοση: (2020-01-01)

The Role of Pretreatment 18F-FDG PET/CT for Early Prediction of Neoadjuvant Chemotherapy Response in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
ανά: Yao J, κ.ά.
Έκδοση: (2021-10-01)

Predictors of complete response to neoadjuvant chemotherapy in non-metastatic bladder cancer
ανά: P. Sousa Passos, κ.ά.
Έκδοση: (2020-11-01)

Whole transcriptome analysis of breast tumors during neoadjuvant chemotherapy: association with response to preoperative chemotherapy. Additional material
ανά: M. K. Ibragimova, κ.ά.
Έκδοση: (2022-03-01)

Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study
ανά: Rui-Qin Zhou, κ.ά.
Έκδοση: (2023-05-01)

[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial
ανά: Giulia Polverari, κ.ά.
Έκδοση: (2020-10-01)

Correlation Between 18F-FDG PET/CT SUVmax and Clinicopathological Features, Neoadjuvant Chemotherapy Response in Invasive Ductal Breast Carcinoma Patients
ανά: LU Shengnan, κ.ά.
Έκδοση: (2019-02-01)

Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
ανά: Willard Wong, κ.ά.
Έκδοση: (2021-07-01)